Loading clinical trials...
Loading clinical trials...
Rationale: improving the early detection of AD at prodromal pre-dementia stages has become a major matter of concern. There is now an important body of literature stating that early isolated cognitive...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Tours
NCT07666113 · Alzheimer's Disease (AD)
NCT06347315 · Mild Cognitive Impairment
NCT07652775 · Mild Cognitive Impairment (MCI), Depressive Symptoms
NCT07214727 · Alzheimer's Disease
NCT06745583 · Mild, Moderate, or Severe Alzheimer's Disease
university hospital of CAEN
Caen
University Hospital of Lille
Lille
University Hospital of Toulouse
Toulouse
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions